PCI 3.06.26

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Upcoming Events

CPHI 2027
AI in Drug Discovery
DDL 2026
Biotechnology Show 13.02.26

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View

Advertisement

Bachem skyscraper

Advertisement

Fujifilm
news

MedPharm Names Christy Mocny Vice President of Quality

MedPharm, a global leader in topical and transdermal contract drug development and manufacturing, has appointed Christy Mocny as Vice President of Quality. The a...
Continue Reading →
news

Sharpak Healthcare Demonstrates Up to 88.6% Carbon Reduction Through Reusable Sharps Containers

Independent Life Cycle Assessment provides verified evidence of the carbon performance of Sharpak Zero reusable sharps bins. Sharpak Healthcare has quanti...
Continue Reading →
news

Pheno Therapeutics granted two key patents protecting its selective GPR17 antagonist pipeline targeting neurological diseases

Patents cover a polymorph (crystalline form) of PTD802, Pheno's lead clinical candidate, and a composition of matter covering PTD939, Pheno's second GPR17 antag...
Continue Reading →
news

Calla Lily Clinical Care awarded Innovate UK grant to expand Callavid platform for vaginal microbiome health

£700k Growth Catalyst award supports adaptation of Callavid intravaginal drug delivery platform for live biotherapeutic products and probiotics Programme add...
Continue Reading →
news

Nuclera and University of Cambridge researchers demonstrate rapid structural analysis of challenging drug target

Collaboration combines cell-free protein synthesis, proprietary nanodisc technology and cryo-electron microscopy (cryo-EM) to enable high-resolution structural ...
Continue Reading →
news

Enterprise Therapeutics granted EMA orphan medicinal product designation for novel cystic fibrosis therapy, ETD001

·        Investigational inhaled ENaC blocker developed to treat people with cystic fibrosis not benefiting from CFTR modulators ·    &nbs...
Continue Reading →
news

Moroxite Receives Second FDA Breakthrough Device Designation

Moroxite AB, a Swedish medical technology company developing biomaterials for bone healing in spinal surgery, has received its second Breakthrough Device Designa...
Continue Reading →
news

CPHI Milan celebrates record attendance figures at this year’s event

63,000 attendees from 168 countries were welcomed to the Fiera Milano CPHI Milan has announced record attendance figures for this year's major event, welc...
Continue Reading →
news

TRIMTECH Therapeutics enters strategic research collaboration with Biogen to advance small molecule degraders for neurodegenerative disease

Collaboration with Biogen will leverage TRIMTECH's proprietary TRIM21-based targeted protein degradation technology to develop novel protein degrading therapeut...
Continue Reading →
news

Laverock Therapeutics appoints Parker Moss as Chief Executive Officer and Paul J. Sekhri as Executive Chairman

Appointment of experienced transatlantic leadership team, based in London and New York, to support lead programmes' progression into the clinic Interim Chair...
Continue Reading →

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity

Advertisement

Crown Bioscience

Advertisement

Shimadzu

Advertisement

CPC